David Lucchino ’06 and Prof. Robert Langer have co-founded Frequency Therapeutics, a biotechnology company focused on developing a new approach to restoring hearing from the most common form of hearing loss, reports Jack Kelly for Forbes. “FX-322 is designed to treat the underlying cause of SNHL (sensorineural hearing loss) by regenerating sensory hair cells through activation of progenitor cells already present in the cochlea,” writes Kelly.
Wall Street Journal reporter John Anderson spotlights “Augmented” a new PBS documentary featuring Prof. Hugh Herr and his work in robotic limbs and surgery.
A new documentary titled “Augmented” spotlights Prof. Hugh Herr and his work developing bionic limbs at the MIT Media Lab, reports Dana Gerber for The Boston Globe. “The long-term hope for the procedure is that people with Ewing amputations will be able to further adapt to the bionic limbs shown in the film, which Herr’s team is developing at MIT,” writes Gerber.
MIT researchers have developed a transparent, degradable medical dressing that could be used to help gut wounds heal more quickly and efficiently without leaking bacteria, reports Alex Wilkins for New Scientist. The researchers “designed their dressing to work like duct tape, which is only sticky on one side,” writes Wilkins. “Once it covers the wound, it quickly forms a hydrogel, an adhesive layer that can help the wound to heal.”
STAT reporters Katie Palmer and Casey Ross spotlight how Prof. Regina Barzilay has developed an AI tool called Mirai that can identify early signs of breast cancer from mammograms. “Mirai’s predictions were rolled into a screening tool called Tempo, which resulted in earlier detection compared to a standard annual screening,” writes Palmer and Ross.
Salon reporter Elizabeth Landau spotlights the work of researchers from MIT and the Massachusetts Eye and Ear Infirmary in uncovering how Covid-19 can affect the ear. Viruses such as Covid-19, “all have these tentacles that seem to touch the ear, but nobody’s been able to study them because the ear is so inaccessible,” says Prof. Lee Gehrke. “So that’s the part that I think I get most excited about. Now we have a way to look at these things in a way that we were not able to do before.”
In an article for The Wall Street Journal about next generation technologies that can create and quantify personal health data, Laura Cooper spotlights Prof. Dina Katabi’s work developing a noninvasive device that sits in a person’s home and can help track breathing, heart rate, movement, gait, time in bed and the length and quality of sleep. The device “could be used in the homes of seniors and others to help detect early signs of serious medical conditions, and as an alternative to wearables,” writes Cooper.
MIT researchers are developing innovations aimed at improving Covid-19 diagnostics, including an atomic-level test designed to increase testing accuracy, reports Steven Zeitchik for The Washington Post. Professor James Collins and his team are developing “a mask that uses freeze-dried technology to detect the coronavirus.”
Prof. Regina Barzilay speaks with Good Morning America about her work developing a new AI tool that could “revolutionize early breast cancer detection” by identifying patients at high risk of developing the disease. “If this technology is used in a uniform way,” says Barzilay, “we can identify early who are high-risk patients and intervene.”
Washington Post reporter Steve Zeitchik spotlights Prof. Regina Barzilay and graduate student Adam Yala’s work developing a new AI system, called Mirai, that could transform how breast cancer is diagnosed, “an innovation that could seriously disrupt how we think about the disease.” Zeitchik writes: “Mirai could transform how mammograms are used, open up a whole new world of testing and prevention, allow patients to avoid aggressive treatments and even save the lives of countless people who get breast cancer.”
Prof. Timothy Lu, Prof. Jim Collins and Philip Lee ’03 co-founded Senti Bio, a biotechnology company that uses gene circuit technology to create cell and gene therapies that can sense and respond to ailments inside the body, reports Sohini Podder for Reuters. “The way I like to think about it – just like you can program a computer with different programs or different maps, we can do the same thing with medicines,” says Lu.
NPR’s Ted Radio Hour spotlights the work of Alicia Chong Rodriguez SM ’17, SM ’18, who is trying to address the gaps that exist in women’s health data through a smart bra that can be used to acquire physiological data. Chong’s startup BloomerTech has “built medical-grade textile sensors that can adapt to multiple bra styles and sizes for continuous, reliable and repeatable data all around her torso and her heart.”
Researchers from MIT and Massachusetts Eye and Ear have found that Covid-19 can cause long-term issues with a patient’s ear, reports Matthew Rozsa for Salon. The researchers found that the SARS-CoV-2 virus is capable of infecting the hair cells of the inner ear, as well as (to a lesser extent) the Schwann cells,” Rozsa explains.
Forbes reporter William A. Haseltine spotlights an MIT and Massachusetts Eye and Ear study that finds the inner ear can be infected by Covid-19. “When exposed to SARS-CoV-2,” writes Haseltine, the researchers, "found that the vestibular hair cells on the inner ear, which helps us keep our balance and sense head movements, had an infection rate of 26%, making them particularly vulnerable."
Scientific American reporter Emily Sohn writes that MIT researchers have found that vision and hearing can be impacted by the virus that causes Covid-19. “The data are growing to suggest that there are more neural consequences of this infection than we originally thought,” says Prof. Lee Gehrke.